Prism Vision Group: Clinical Trials

3 completed, 1 unknown. 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	2	Completed 1, Unknown 1

Follow Prism Vision Group: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy Dextenza 0.4Mg Ophthalmic Insert - Dry Eye Disease, Cataract Surgery	Phase 4	Unknown	Prism Vision Group	35	2021-01-01	2020-12-11
DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses Dexamethasone, Prednisolone Acetate 1% Oph Susp - Cataract	Phase 4	Completed	Prism Vision Group	13	2020-10-01	2023-06-22
Resistance to Antibiotics in Patients Receiving Eye Injections Conjunctival and nasopharyngeal swabs - Age-Related Macular Degeneration, Retinal Vein Occlusion		Completed	Prism Vision Group	40	2014-05-01	2016-06-01
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. Neovascular Age Related Macular Degeneration		Completed	Prism Vision Group	136	2013-12-01	2016-06-01

Conditions studied

Cataract (1)  ·  Diabetic Retinopathy (1)  ·  Dry Eye Syndromes (1)  ·  Macular Degeneration (1)  ·  Retinal Vein Occlusion (1)

Interventions

Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  prednisolone acetate (1)

Countries

United States (3)

Top investigators

Cynthia Matossian, MD (1)  ·  Daniel Roth, MD (1)  ·  Howard Fine, MD, MHSc (1)